280E Updates: Rescheduling, Amending Returns, and Why Timing Matters - Sign up for our free webinar now!

280E Updates: Rescheduling, Amending Returns, and Why Timing Matters - Sign up for our free webinar now!

Aurora Cannabis Buys Anandia Laboratories in All-Stock Deal Valued at $115 Million | Cannabis Business Times

Sign in or create a free Cannabis Business Times account to continue reading

Continue to Site »
Site will load in 15 seconds

Continue to Site »X

Aurora Cannabis Buys Anandia Laboratories in All-Stock Deal Valued at $115 Million

Anandia provides research and development services as well as analytical testing for clients licensed under Canada’s medical cannabis rules.

Cannabis Plant Adobe Stock Credit Miravision Resized

June 13, 2018

Aurora Cannabis Inc. has signed an agreement to buy Anandia Laboratories Inc. in an all-stock deal valued at $115-million.

Anandia provides research and development services as well as analytical testing for clients licensed under Canada’s medical cannabis rules.

Aurora CEO Terry Booth says the deal expands his company’s capabilities and will help accelerate product development.

Top Image: © Miravision | Adobe Stock

280E Updates: Rescheduling, Amending Returns, and Why Timing Matters - Sign up for our free webinar!

ACT LAB Expands National Laboratory Network to New Jersey

Verdant Completes Acquisition of 15 Native Roots Dispensaries in Colorado

Vireo Growth Announces 4-Deal Transaction to Establish Ohio Presence With 8 Dispensaries

Curaleaf Intends to Launch Takeover Bid for Aurora Cannabis

Curaleaf is taking its proposal directly to Aurora shareholders after repeated attempts to engage privately failed to gain substantive discussions.

Curaleaf m&a 510218937

ACT LAB Expands National Laboratory Network to New Jersey

Building on trusted local expertise, ACT LAB brings enhanced testing methodologies and regulatory guidance to New Jersey’s regulated cannabis market.

Verdant Completes Acquisition of 15 Native Roots Dispensaries in Colorado

The transaction establishes Verdant's retail operating platform and positions the company for continued growth through acquisitions.

Founded in 2009, Native Roots enters a new era under Verdant Partners, with a clear focus on disciplined operations and raising the standard for cannabis retail in Colorado.

Vireo Growth Announces 4-Deal Transaction to Establish Ohio Presence With 8 Dispensaries

The $208 million agreements further expand Vireo’s national platform, creating one of the cannabis industry’s broadest state footprints.

SNDL Acquires Assets From Parallel, Positions for Nasdaq-Consolidated Operations

The acquisition includes 56 dispensaries and three cultivation and manufacturing facilities in Florida, Massachusetts and Texas.

Vireo Growth to Acquire Planet 13 Holdings, Add 36 Dispensaries

The transaction is expected to deepen Vireo's positions in Nevada and Florida, complement its growing Illinois platform, and further strengthen one of the industry's broadest multistate cannabis operating platforms.

FLUENT Selling New York License, Certain Operations

The cannabis company entered into a definitive agreement with a third-party operator to sell Etain, which is FLUTENT’s operating entity in the state.

Vireo Growth to Acquire Certain Assets of The Cannabist Co. in 5 States for $35 Million

Vireo will expand operations in one market and enter four additional states through a definitive agreement, including up to 25 dispensaries.

Vireo Growth Completes Acquisition of Pennsylvania Dispensary License Transaction

The transaction authorizes the company to operate up to six dispensaries in the commonwealth, subject to regulatory approval.

Standard Wellness Announces Cleveland Expansion, Ohio Retail Portfolio Repositioning

The multistate cannabis operator entered into a definitive agreement to acquire License in the Flats LLC’s dispensary.

Vireo Growth Announces Pennsylvania Dispensary License Transaction

The roughly $20 million transaction will allow the company to expand into its 11th state cannabis market.

InterCure Initiates Review of US Medical Cannabis Opportunities Following Federal Rescheduling

The company completed the initial closing of its acquisition of Botanico, expanding its international platform with exclusive access to U.S. genetics.

Page 1 of 60